Goa-based Molbio Diagnostics, which provides innovative solutions for universal access to high-quality healthcare, announced that Temasek has invested $85 million in the company. Molbio is known for its game-changing Truenat® technology – a point-of-care, portable, battery-operated Real-Time PCR platform. Hailed globally as a high-impact breakthrough